Biocons Generic Formulations Facility in Bengaluru completes U.S. FDA Inspection with No 483 observations
Ask Value Research 
News Announcement
Biocon: Announcement Under Regulation 30 Of SEBI Listing Obligations And Disclosure Requirements Regulations, 2015
12-Nov-2018
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
